SCHEMBL22036723

SCHEMBL22036723

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c3c3c5ccccc5c5cccc4n53)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.37
L3MBTL1 Q9Y468 4/20 0.37
KDM4E B2RXH2 4/20 0.37
MAPK1 P28482 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HTT P42858 1/20 0.36
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ACHE P22303 1/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33
ATM Q13315 2/20 0.33
CYP19A1 P11511 2/20 0.32
CYP11B1 P15538 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22036685 0.90 MAPT (0.35) MAPTL3MBTL1KDM4EMAPK1NPSR1
SCHEMBL22035868 0.87 KDM4E (0.34) MAPTL3MBTL1KDM4EMEN1KMT2A
SCHEMBL23474714 0.86 MAPT (0.34) MAPTL3MBTL1KDM4EMAPK1NPSR1
SCHEMBL22036135 0.85 MEN1 (0.38) MAPTL3MBTL1KDM4EMEN1KMT2A
SCHEMBL21449288 0.85 MAPT (0.33) MAPTL3MBTL1KDM4EMAPK1NPSR1
SCHEMBL19890653 0.85 MAPT (0.33) MAPTL3MBTL1KDM4EMAPK1NPSR1
SCHEMBL23487174 0.85 MAPT (0.35) MAPTL3MBTL1KDM4EMAPK1NPSR1
SCHEMBL22172035 0.84 L3MBTL1 (0.32) MAPTL3MBTL1KDM4EMAPK1NPSR1
SCHEMBL23474672 0.84 MAPT (0.33) MAPTL3MBTL1KDM4EMAPK1NPSR1
SCHEMBL23474657 0.84 MAPT (0.33) MAPTL3MBTL1KDM4EMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11535619-B2 Hexacyclic heteroaromatic compounds for electronic devices MERCK PATENT GMBH (DE) 2022-12-27 US disclosed
US-20200165252-A1 HEXACYCLIC HETEROAROMATIC COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165252-A1 HEXACYCLIC HETEROAROMATIC COMPOUNDS FOR ELECTRONIC DEVICES ETV6, CYP2J2, CYP2D6 MAPT 2751/4885L3MBTL1 3859/4885KDM4E 2237/4885
US-11535619-B2 Hexacyclic heteroaromatic compounds for electronic devices ETV6, CYP2J2, CYP2D6 MAPT 2751/4885L3MBTL1 3859/4885KDM4E 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.